Medicale Corp.
MCLE
$0.03
-$0.01-16.13%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -79.33% | -43.87% | -61.29% | -40.57% | -22.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -79.33% | -43.87% | -61.29% | -40.57% | -22.28% |
| Operating Income | 79.33% | 43.87% | 61.29% | 40.57% | 22.28% |
| Income Before Tax | 68.26% | 36.69% | 47.62% | 28.45% | 13.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 68.26% | 36.69% | 47.62% | 28.45% | 13.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 68.26% | 36.69% | 47.62% | 28.45% | 13.47% |
| EBIT | 79.33% | 43.87% | 61.29% | 40.57% | 22.28% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 67.86% | 37.93% | 50.00% | 30.00% | 15.15% |
| Normalized Basic EPS | 66.67% | 38.89% | 45.45% | 25.00% | 10.00% |
| EPS Diluted | 67.86% | 37.93% | 50.00% | 30.00% | 15.15% |
| Normalized Diluted EPS | 66.67% | 38.89% | 45.45% | 25.00% | 10.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |